BiotechTube
Alpenglow Biosciences

Alpenglow Biosciences

Boulder, United States· Est.
alpenglowbiosciences.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Alpenglow Biosciences is a private company pioneering 3D histology imaging and AI-powered digital pathology. Its Aurora 3D™ platform integrates proprietary hardware (3Di™ microscope), software (3Dm™ data management), and AI analytics (3Dai™) to generate spatial biology insights from whole, intact tissue specimens, moving beyond traditional 2D slide analysis. The company is revenue-generating through its platform and services, with a focus on applications in immuno-oncology, dermatology, and neuroscience, and has secured significant non-dilutive funding and key partnerships to advance its technology towards clinical diagnostics.

OncologyDermatologyImmunologyNeuroscience

Technology Platform

Aurora 3D™ platform integrating proprietary open-top light-sheet microscopy (3Di™), automated 3D data management software (3Dm™), and AI-driven image analysis (3Dai™) for end-to-end 3D spatial biology analysis of intact tissue specimens.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The transition from 2D to 3D tissue analysis represents a paradigm shift in pathology and spatial biology, offering a significant market opportunity in both research and clinical diagnostics.
Strategic partnerships with diagnostic companies and clinics provide a direct pathway to clinical adoption and revenue growth.
Substantial non-dilutive government funding de-risks R&D and validates the technology's potential for high-impact applications.

Risk Factors

The company faces competition from established imaging firms and other spatial biology startups, and must overcome entrenched 2D workflows.
The path to regulatory approval for clinical diagnostics is long, costly, and uncertain.
Scaling operations for both hardware and service offerings while maintaining quality presents an execution challenge.

Competitive Landscape

Alpenglow competes in the spatial biology and digital pathology market against large imaging companies (e.g., Leica, Philips, 3DHistech) offering 2D/3D slide scanners and software, and specialized 3D imaging startups (e.g., RareCyte, Lunaphore). Its key differentiation is the integrated end-to-end platform for intact tissue 3D imaging and analysis, combining proprietary hardware and AI in a single workflow.

More companies in Diagnostics & Precision Medicine →More companies in United States →